Cited by 178T-cell and Retrovirus StudiesHIV Research and TreatmentViral-associated cancers and disorders

Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission

Open access
Van Prooyen, Nancy, Gold, Heather, Andresen, Vibeke, Schwartz, Owen, Jones, Kathryn, Ruscetti, Frank, Lockett, Stephen, Gudla, Prabhakar +2 more·2010·Proceedings of the National Academy of Sciences

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) is the cause of adult T-cell leukemia/lymphoma as well as tropical spastic paraparesis/HTLV-1–associated myelopathy. HTLV-1 is transmitted to T cells through the virological synapse and by extracellular viral assemblies. Here, we uncovered an additional mechanism of virus transmission that is regulated by the HTLV-1–encoded p8 protein. We found that the p8 protein, known to anergize T cells, is also able to increase T-cell contact through lymphocyte function-associated antigen-1 clustering. In addition, p8 augments the number and length of cellular conduits among T cells and is transferred to neighboring T cells through these conduits. p8, by establishing a T-cell network, enhances the envelope-dependent transmission of HTLV-1. Thus, the ability of p8 to simultaneously anergize and cluster T cells, together with its induction of cellular conduits, secures virus propagation while avoiding the host's immune surveillance. This work identifies p8 as a viral target for the development of therapeutic strategies that may limit the expansion of infected cells in HTLV-1 carriers and decrease HTLV-1–associated morbidity.

Integrity signals

Registry

Crossref · 10.1073/pnas.1009635107

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HTLV-1 p8 protein plays an important role in transmission through conduits; p8 increases number and length of conduits, enhances intercellular contacts, induces LFA-1 clustering, translocates along conduits into recipient T cells, suppresses TCR signaling, leads to T cell anergy, and attenuates immune recognition of infected cells.

    “The viral p8 protein plays an important role in the transmission of HTLV-1 through conduits. p8 is generated by a two-step proteolytic cleavage of the p12 protein encoded by open reading frame 1 (orf-1) in the HTLV-1 genome [117]. p8 increases the number and length of conduits, and enhances intercellular contacts, inducing clustering of LFA-1. Furthermore, p8 is rapidly translocated along conduits”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Van Prooyen, N., Gold, H., Andresen, V., Schwartz, O., Jones, K., Ruscetti, F., Lockett, S., Gudla, P., Venzon, D., & Franchini, G.
Affiliations
  • Animal Models Retroviral Vaccine Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;
  • National Institutes of Health (US)
  • National Cancer Institute (US)
  • Frederick National Laboratory for Cancer Research (US)
Corresponding author
Franchini, Genoveffa
Venue
Proceedings of the National Academy of Sciences
Published
2010-11-12
Volume
107
Issue
48
Pages
20738-20743
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2038365894
Cited by
178
References
7
Citations by year
2026: 4 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 12 · 2021: 11 · 2020: 16 · 2019: 11 · 2018: 10 · 2017: 17 · 2016: 7 · 2015: 9 · 2014: 10 · 2013: 18 · 2012: 12
FWCI
5.91
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute (HHSN261200800001E)
  • National Institutes of Health (#HHSN261200800001E, HHSN261200800001C, Contract HHSN261200800001E)
  • National Cancer Institute (Contract HHSN261200800001E, HHSN261200800001E))
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Keywords
HTLV-1, p8 protein, virus transmission, T cell anergy, virological synapse, adult T-cell leukemia/lymphoma, tropical spastic paraparesis
MeSH terms
Cell Communication, Humans, Kinetics, T-Lymphocytes, Viral Proteins, Human T-lymphotropic virus 1, HTLV-I Infections, Jurkat Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review